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Retrospective Review of BioFire’s FilmArray Gastrointestinal Panel’s Detection of 
Multiple Pathogens in Adult Patients: A Hypothesis Generating Study
•  Our study highlights a high frequency (16.8%) of pathogen co-
detection in patients with a positive stool PCR test
•  It also suggests that bacterial-viral co-detections are the most 
commonly identified combination
•  The most frequent pathogen-specific combination was 
Norovirus with C. difficile accounting for 19.3% of co-
detections
•  More information is needed on the significance of co-
detections and their treatment
•  Further analysis will evaluate the contribution of demographics 
and immunosuppressing conditions to the likelihood of co-
detection
•  Pathogens are only identified in 1.5 to 5.6 percent of stool cultures for acute diarrhea1  
•  Multiplex stool PCR is an accurate diagnostic tool to detect multiple intestinal pathogens in a single 
sample with rapid turnaround and high sensitivity/specificity 
•  BioFire’s FilmArray Gastrointestinal Panel is an FDA approved syndromic multiplex PCR assay which 
evaluates stool for 22 common bacterial, viral and parasitic targets
  –  Campylobacter spp., Clostridium difficile toxins, Plesiomonas shigelloides, Salmonella, Yersinia 
enerocolitica, Vibrio spp., Diarrheagenic E. coli/Shigella, Enteroaggregative E. coli, Enteropathogenic 
E. coli, Enterotoxigenic E. coli, Shiga-like toxin-producing E. coli, Shigella/Enteroinvasive E. coli, 
Cryptosporidium, Cyclospora cayetanensis, Entamoeba histolytica, Giardia lamblia, Adenovirus, 
Astrovirus, Norovirus, Rotavirus A, and Sapovirus
•  Major advantages include rapid turnaround time, identification of coinfections, high negative predictive 
value which decreases the use of infection control precautions, and high sensitivity and specificity2
•  The test’s sensitivity ranges between 94.5%-100% and specificity ranges between 97.1-100%3
•  In studies using multiplex assays there has been a notable increase in the detection of multiple 
pathogens within one stool sample.  One study found as many as 31.5% of stool samples that were 
positive had multiple pathogens detected; another study found that 18% of immunosuppressed patients 
with positive stool test were coinfected3-4
•  Currently the clinical implication of detecting multiple pathogens is poorly understood
•  The study was designed as a retrospective, descriptive, hypothesis-generating study to evaluate the co-
detection of pathogens with BioFire FilmArray Gastrointestinal Panel in an adult community population
•  Patients with stool PCR positive for ≥1 pathogen within the date range of 01/01/15-06/30/16 were 
obtained
•  Inclusion criteria was age ≥18 and having a stool PCR with ≥1 pathogen within a community health 
network in the study date range
•  Patients with tests repeated within 14 days of initial sample were excluded from the analysis
•  Demographic data at the time of sample collection were obtained
•  710 patients with pathogen detection
•  119 patients with a pathogen detected had >1 pathogen (16.8%)
•  Bacterial-viral co-detections were seen in 50.4% of co-detection samples, while 39.5% of co-detections 
were bacterial-bacterial (Table 1)
•  Viral-viral, bacterial-parasitic, and bacterial-parasitic-viral co-detections were less frequent 
•  Certain organisms when positive on stool PCR testing, had a ≥50% occurrence as a co-detection rather 
than in isolation:
  –  E. coli O157:H7 100% (1/1), P. shigelloides 83% (5/6), Sapovirus 70.6% (12/17), EAEC 62.9% (22/35), 
and Cryptosporidium 50% (3/6) when positive on stool PCR testing 
•  The most common patterns 
of co-detection were 
Norovirus/C. difficile (19.3%), 
EPEC/C. difficile (7.6%), 
EPEC/Campylobacter (5.9%), 
and EPEC/Norovirus (5.9%) 
(Table 2)
•  Currently the clinical 
implication of detecting 
multiple pathogens is poorly 
understood
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Table 1.  Organism Classification in Co-Detections






METHODS Table 2.  Incidence of Pathogens
Highest Incidence of Co-Detected Pathogens Incidence
C. difficile, Norovirus 19.3% (23/119)
C. difficile, EPEC 7.6% (9/119)
Campylobacter, EPEC 5.9% (7/119)
EPEC, Norovirus 5.9% (7/119)
C. difficile, EAEC 4.2% (5/119)
EAEC, EPEC 4.2% (5/119)
